Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Myers

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Endocrinology|May 14, 2004
Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)?Alison M Strack, Robert W Myers
Analytical Biochemistry|June 15, 2010
Enzymatic preparation of high-specific-activity beta-D-[6,6'-3H]fructose-2,6-bisphosphate: Application to a sensitive assay for fructose-2,6-bisphosphataseRobert W Myers, Walter F Baginsky, David J Gattermeir, et al.
Frontiers in Bioscience (Scholar Edition)|April 22, 2016
Moderate to high throughput in vitro binding kinetics for drug discoveryRumin Zhang, Christopher M Barbieri, Margarita Garcia-Calvo, et al.
Psychiatric Services (Washington, D.C.)|May 7, 2021
Defining and Addressing Gaps in Care for Obsessive-Compulsive Disorder in the United StatesMeredith S Senter, Sapana R Patel, Lisa B Dixon, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2021
Statewide Workforce Development Program to Improve Care for Individuals With Obsessive-Compulsive DisorderSapana R Patel, Marina Gershkovich, Melissa Hinds, et al.
Psychiatric Services (Washington, D.C.)|December 24, 2011
Public-academic partnerships: a public-academic partnership to support a state mental health authority's strategic planning and policy decisionsAnthony Salerno, Lisa B Dixon, Robert W Myers, et al.
Frontiers in Physiology|March 23, 2023
Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potentialThomas Rossetti, Jacob Ferreira, Lubna Ghanem, et al.
Frontiers in Physiology|October 17, 2022
Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potentialThomas Rossetti, Jacob Ferreira, Lubna Ghanem, et al.
RSC Medicinal Chemistry|August 6, 2021
Deglycase-activity oriented screening to identify DJ-1 inhibitorsIgor Maksimovic, Efrat Finkin-Groner, Yoshiyuki Fukase, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Use of administrative data to identify potential service gaps for individuals with serious mental illnessThomas E Smith, Anita Appel, Sheila A Donahue, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Endocrinology|May 14, 2004
Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)?Alison M Strack, Robert W Myers
Analytical Biochemistry|June 15, 2010
Enzymatic preparation of high-specific-activity beta-D-[6,6'-3H]fructose-2,6-bisphosphate: Application to a sensitive assay for fructose-2,6-bisphosphataseRobert W Myers, Walter F Baginsky, David J Gattermeir, et al.
Frontiers in Bioscience (Scholar Edition)|April 22, 2016
Moderate to high throughput in vitro binding kinetics for drug discoveryRumin Zhang, Christopher M Barbieri, Margarita Garcia-Calvo, et al.
Psychiatric Services (Washington, D.C.)|May 7, 2021
Defining and Addressing Gaps in Care for Obsessive-Compulsive Disorder in the United StatesMeredith S Senter, Sapana R Patel, Lisa B Dixon, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2021
Statewide Workforce Development Program to Improve Care for Individuals With Obsessive-Compulsive DisorderSapana R Patel, Marina Gershkovich, Melissa Hinds, et al.
Psychiatric Services (Washington, D.C.)|December 24, 2011
Public-academic partnerships: a public-academic partnership to support a state mental health authority's strategic planning and policy decisionsAnthony Salerno, Lisa B Dixon, Robert W Myers, et al.
Frontiers in Physiology|March 23, 2023
Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potentialThomas Rossetti, Jacob Ferreira, Lubna Ghanem, et al.
Frontiers in Physiology|October 17, 2022
Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potentialThomas Rossetti, Jacob Ferreira, Lubna Ghanem, et al.
RSC Medicinal Chemistry|August 6, 2021
Deglycase-activity oriented screening to identify DJ-1 inhibitorsIgor Maksimovic, Efrat Finkin-Groner, Yoshiyuki Fukase, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Use of administrative data to identify potential service gaps for individuals with serious mental illnessThomas E Smith, Anita Appel, Sheila A Donahue, et al.
Pageof 6